Predictors of remission from body dysmorphic disorder after internet-delivered cognitive behavior therapy: a machine learning approach

Abstract Background Previous attempts to identify predictors of treatment outcomes in body dysmorphic disorder (BDD) have yielded inconsistent findings. One way to increase precision and clinical utility could be to use machine learning methods, which can incorporate multiple non-linear associations...

Full description

Bibliographic Details
Main Authors: Oskar Flygare, Jesper Enander, Erik Andersson, Brjánn Ljótsson, Volen Z. Ivanov, David Mataix-Cols, Christian Rück
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Psychiatry
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12888-020-02655-4
Description
Summary:Abstract Background Previous attempts to identify predictors of treatment outcomes in body dysmorphic disorder (BDD) have yielded inconsistent findings. One way to increase precision and clinical utility could be to use machine learning methods, which can incorporate multiple non-linear associations in prediction models. Methods This study used a random forests machine learning approach to test if it is possible to reliably predict remission from BDD in a sample of 88 individuals that had received internet-delivered cognitive behavioral therapy for BDD. The random forest models were compared to traditional logistic regression analyses. Results Random forests correctly identified 78% of participants as remitters or non-remitters at post-treatment. The accuracy of prediction was lower in subsequent follow-ups (68, 66 and 61% correctly classified at 3-, 12- and 24-month follow-ups, respectively). Depressive symptoms, treatment credibility, working alliance, and initial severity of BDD were among the most important predictors at the beginning of treatment. By contrast, the logistic regression models did not identify consistent and strong predictors of remission from BDD. Conclusions The results provide initial support for the clinical utility of machine learning approaches in the prediction of outcomes of patients with BDD. Trial registration ClinicalTrials.gov ID: NCT02010619 .
ISSN:1471-244X